Michelle Carnahan

Michelle Carnahan serves as President of Thirty Madison, where strategic leadership has led to a dramatic increase in company valuation, achieving unicorn status. With a broad portfolio of advisory roles in healthcare, including positions at Stripes and Sage Pharmaceuticals Inc., Michelle develops market access strategies and guides investment opportunities. Previous experience includes key leadership positions at Sanofi and Eli Lilly and Company, where impactful transformations in market strategy and operations resulted in significant revenue growth. A graduate of DePauw University, Michelle holds a Bachelor of Applied Science in Economics.